Table 1.
Baseline characteristics of the included studies.
| Author | Study Design | Sample Size | Gender (% Males) | Other Biomarkers Investigated |
||
|---|---|---|---|---|---|---|
| Gp A | Gp B | Gp A | Gp B | |||
| Pham et al., 2016 [17] | Retro | 179 | 213 | 63% | 69% | WBC |
| Besli et al., 2019 [18] | Retro | 245 | 158 | 70% | 64% | WBC, NP, CRP |
| Lindestam et al., 2019 [11] | Pro | 15 | 65 | 80% | 63% | CRP, WBC, plasma glucose, BE, plasma AVP |
| Yang et al., 2019 [19] | Retro | 613 | 1282 | 54% | 52% | CRP, WBC, NP, PC, PCT, DLAC, Bilirubin, AST, ALT |
| Pogorelić et al., 2021 [10] | Pro | 38 | 146 | 71% | 63% | WBC, CRP, NP, potassium, chloride, glucose |
| Duman et al., 2022 [20] | Retro | 82 | 254 | 2:1 * | CRP, WBC, NP, MLR, NLR, PLR, MPV | |
| Walsh et al., 2022 [21] | Retro | 443 | 690 | 60% | 61.4% | - |
* Group-wise gender distribution not mentioned. In this study, M:F ratio among the appendicitis group was 2:1.